Cargando…
Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
Age is a known predictor of blood pressure (BP); however, the literature mostly includes cross‐sectional investigations. This prospective cohort study aimed to decompose the cross‐sectional and longitudinal age effects on BP. The secondary data were obtained from the Tehran lipid and glucose study,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678670/ https://www.ncbi.nlm.nih.gov/pubmed/33720477 http://dx.doi.org/10.1111/jch.14238 |
_version_ | 1784616356053778432 |
---|---|
author | Khajavi, Alireza Zayeri, Farid Ramezankhani, Azra Nazari, Amir Azizi, Fereidoun Hadaegh, Farzad |
author_facet | Khajavi, Alireza Zayeri, Farid Ramezankhani, Azra Nazari, Amir Azizi, Fereidoun Hadaegh, Farzad |
author_sort | Khajavi, Alireza |
collection | PubMed |
description | Age is a known predictor of blood pressure (BP); however, the literature mostly includes cross‐sectional investigations. This prospective cohort study aimed to decompose the cross‐sectional and longitudinal age effects on BP. The secondary data were obtained from the Tehran lipid and glucose study, which comprised six repeated measurements of participants, with median follow‐up of 15.8 (interquartile range of 14.2‐16.9) years. The sample is representative of the metropolitan area of Tehran, Iran, containing 7,460 participants aged 20‐70. The cross‐sectional and longitudinal effects of age (age at baseline and aging, respectively) were fitted in the mixed effects models, taking systolic, diastolic, and pulse BPs as response, adjusting for adiposity, smoking, diabetes, and antihypertensive medication, and stratifying for sex and 10‐year age‐groups. The mean age at baseline was 41.3 (SD = 12.9) years, and 41.7% of the participants were male. Age at baseline and aging were directly associated with BP, aging owned the weaker effect, and the largest distinction were for systolic blood pressure of men aged 40‐49 years (0.75 vs 0.10, p‐value < .001). Moreover, the aging effects on systolic and diastolic BPs were higher in men than women, in the age groups 40‐49 and 30‐39 years (0.35 vs 0.10 and 0.30 vs 0.07, p‐values < .001), respectively. Adjusting for adiposity remarkably declined the impact of aging on BP, among the < 50 years old. |
format | Online Article Text |
id | pubmed-8678670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86786702021-12-23 Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study Khajavi, Alireza Zayeri, Farid Ramezankhani, Azra Nazari, Amir Azizi, Fereidoun Hadaegh, Farzad J Clin Hypertens (Greenwich) Aging Age is a known predictor of blood pressure (BP); however, the literature mostly includes cross‐sectional investigations. This prospective cohort study aimed to decompose the cross‐sectional and longitudinal age effects on BP. The secondary data were obtained from the Tehran lipid and glucose study, which comprised six repeated measurements of participants, with median follow‐up of 15.8 (interquartile range of 14.2‐16.9) years. The sample is representative of the metropolitan area of Tehran, Iran, containing 7,460 participants aged 20‐70. The cross‐sectional and longitudinal effects of age (age at baseline and aging, respectively) were fitted in the mixed effects models, taking systolic, diastolic, and pulse BPs as response, adjusting for adiposity, smoking, diabetes, and antihypertensive medication, and stratifying for sex and 10‐year age‐groups. The mean age at baseline was 41.3 (SD = 12.9) years, and 41.7% of the participants were male. Age at baseline and aging were directly associated with BP, aging owned the weaker effect, and the largest distinction were for systolic blood pressure of men aged 40‐49 years (0.75 vs 0.10, p‐value < .001). Moreover, the aging effects on systolic and diastolic BPs were higher in men than women, in the age groups 40‐49 and 30‐39 years (0.35 vs 0.10 and 0.30 vs 0.07, p‐values < .001), respectively. Adjusting for adiposity remarkably declined the impact of aging on BP, among the < 50 years old. John Wiley and Sons Inc. 2021-03-15 /pmc/articles/PMC8678670/ /pubmed/33720477 http://dx.doi.org/10.1111/jch.14238 Text en © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Aging Khajavi, Alireza Zayeri, Farid Ramezankhani, Azra Nazari, Amir Azizi, Fereidoun Hadaegh, Farzad Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study |
title | Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study |
title_full | Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study |
title_fullStr | Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study |
title_full_unstemmed | Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study |
title_short | Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study |
title_sort | age and aging effects on blood pressure: 15 years follow‐up of tehran lipid and glucose study |
topic | Aging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678670/ https://www.ncbi.nlm.nih.gov/pubmed/33720477 http://dx.doi.org/10.1111/jch.14238 |
work_keys_str_mv | AT khajavialireza ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy AT zayerifarid ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy AT ramezankhaniazra ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy AT nazariamir ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy AT azizifereidoun ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy AT hadaeghfarzad ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy |